Learning Individual Survival Models from PanCancer Whole Transcriptome Data.
Neeraj KumarDaniel SkublenyMichael ParkesRuchika VermaSacha DavisLuke KumarAmira AissiouRussell GreinerPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
NMF-MTLR provides many benefits over other models: superior model discrimination, superior calibration, meaningful survival time estimates, and accurate probabilistic estimates of survival over time for each individual patient. We advocate for the adoption of these cancer survival models in clinical and research settings.